Publication Name	World Journal of Gastroenterology
Manuscript ID	14643
Country	China

Received	2014-10-17 11:04
Peer-Review Started	2014-10-17 11:10
First Decision by Editorial Office Director
Return for Revision	2014-11-17 14:20
Revised	2014-11-24 15:41
Publication Fee Transferred
Second Decision by Editor	2015-01-06 13:39
Second Decision by Editor-in-Chief	2015-01-06 22:15
Final Decision by Editorial Office Director	2015-01-08 17:11
Articles in Press	2015-01-08 17:30
Edit the Manuscript by Language Editor	2015-01-18 06:00
Typeset the Manuscript	2015-02-09 11:44
Publish the Manuscript Online	2015-02-28 17:07

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome
Manuscript Source	Unsolicited Manuscript
All Author List	Fu-Liang He, Lei Wang, Hong-Wei Zhao, Zhen-Hua Fan, Meng-Fei Zhao, Shan Dai, Zhen-Dong Yue and Fu-Quan Liu
Funding Agency and Grant Number
Corresponding Author	Fu-Quan Liu, MD, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Haidian District, Beijing 100038, China. liufq_sjt@163.com
Key Words	Budd-Chiari syndrome; Jaundice; Transjugular intrahepatic portosystemic shunt; Interventional therapy; Percutaneous angioplasty
Core Tip	Jaundice with bilirubin > 51.3 μmol/L (3 mg/dL) is a contraindication for transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis or end-stage liver disease. However, 21 patients in our single center underwent TIPS due to severe jaundice secondary to acute Budd-Chiari syndrome (BCS) and good clinical outcomes were achieved. We present a single center clinical experience and discuss the feasibility and effectiveness of treating severe jaundice secondary to acute BCS with TIPS.
Publish Date	2015-02-28 17:07
Citation	He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol 2015; 21(8): 2413-2418
URL	http://www.wjgnet.com/1007-9327/full/v21/i8/2413.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i8.2413

Full Article (PDF)	WJG-21-2413.pdf
Full Article (Word)	WJG-21-2413.doc
Manuscript File	14643-Review.doc
Answering Reviewers	14643-Answering reviewers.pdf
Biostatistics Review Certificate	14643-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	14643-Conflict-of-interest statement.pdf
Copyright License Agreement	14643-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	14643-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	14643-Language certificate.PDF
Peer-review Report	14643-Peer review(s).pdf
Scientific Misconduct Check	14643-CrossCheck.jpg
Scientific Editor Work List	14643-Scientific editor work list.pdf